Browse the corpus

Extracorporeal shockwave lithotripsy (ESWL) is a minimally invasive surgical procedure for fragmenting renal and ureteral stones. By employing an external machine generating powerful pressure waves, it effectively pulverizes hard concretions like urinary stones into small, passable particles. The procedure is distinguished by its noninvasive nature, allowing the shockwaves to pass harmlessly through soft tissue until focused on the targeted stone, minimizing patient discomfort and facilitating a fast recovery. This activity describes ESWL's applications, including stone chemical composition, anatomical considerations, and patient selection criteria. EWSL is compared to other stone treatment modalities, particularly ureteroscopy, highlighting its invasiveness, patient tolerance, and cost-effectiveness advantages. Further, by emphasizing the collaborative efforts of the interprofessional healthcare team in patient evaluation and care, this activity enhances understanding and proficiency in administering extracorporeal shockwave lithotripsy, ensuring optimal outcomes for patients with nephrolithiasis. Objectives: Identify patients eligible for extracorporeal shockwave lithotripsy based on stone size, composition, location, and patient factors. Select appropriate imaging modalities for preoperative stone localization and targeting in extracorporeal shockwave lithotripsy procedures. Assess patient readiness and suitability for extracorporeal shockwave lithotripsy through comprehensive preoperative assessments and risk stratification. Collaborate with interprofessional team members, including urologists, anesthesiologists, nurses, and technicians, to ensure coordinated care throughout the extracorporeal shockwave lithotripsy process. Access free multiple choice questions on this topic.

Extracorporeal shockwave lithotripsy (ESWL) is a pioneering, noninvasive approach to managing urinary calculi, revolutionizing the landscape of urological care. This innovative procedure harnesses the power of shockwaves to fragment kidney and ureteral stones from outside the body, obviating the need for surgical incisions. Introduced in the 1980s, ESWL has since become a cornerstone in the treatment of urolithiasis, offering patients a safer, less invasive alternative to traditional surgical interventions. ESWL's ability to pulverize stones into smaller, passable fragments, minimal risk profile, and relatively rapid recovery times highlight its significance in contemporary urological practice. Urolithiasis poses a significant burden on the global healthcare system. The prevalence of urinary stones increased from 3.8% in 1970 to 8.8% in 2010, reaching 11% by 2022 in the US alone. This increase is accompanied by annual healthcare costs amounting to $3.8 billion, and continues to escalate.[1] Over an estimated million individuals annually seek emergency room care due to acute renal colic and kidney stone issues, with approximately 20% requiring admission.[2][3] ESWL enhances patient outcomes and alleviates the substantial economic burden associated with urolithiasis by mitigating the need for invasive surgical procedures and reducing hospitalization rates. The cost-effective nature makes ESWL a pivotal tool in promoting both patient well-being and healthcare system sustainability.

Complications of ESWL include: [12][28][36][118][119][120][121][122] Abdominal aneurysm leakage or rupture. Bacteremia, sepsis, and infection (The postoperative risk of infection is about 10%.) Gastrointestinal lesions of various types, with a global incidence of 1.8%. Hematuria, typically self-limiting. Inability to find or target the calculus, which may necessitate additional imaging or ureteroscopy. Incomplete fragmentation leads to ureteral blockage from multiple fragments (steinstrasse) or a single, larger fragment. Steinstrasse occurs in about 3% of all ESWL cases, with only 6% requiring surgical intervention. Treatment is usually conservative but may require a double J stent, ureteroscopy, or a repeat ESWL. Perirenal, subcapsular, or intrarenal hematomas occur in about 1% to 4.6% of cases, with increased risk in anticoagulated patients and those with significant or untreated hypertension. Treatment is usually conservative and supportive, with regular monitoring of hemoglobin and hematocrit. Renal colic in about 40% of patients is usually treated medically with alpha-blockers and analgesics, with a potential need for double-J stenting or ureteroscopy. Renal parenchymal trauma or contusion is typically managed conservatively. Skin contusions and bruising. If no fragmentation occurs after 2 treatments, failure to fragment may warrant repeat ESWL or consideration of alternative therapies such as ureteroscopy.

When a patient presents with renal calculi, the clinician must comprehensively understand medical and surgical treatment options. The patient should be thoroughly educated about the available options, including their relative risks and benefits. With ESWL, explaining the heightened likelihood of retreatment and the potential need for adjunctive therapies is essential.  Preoperative evaluation and preparation play a crucial role in maximizing the success rate of ESWL while minimizing the risk of unforeseen complications. The role of an anesthetist is essential to ensure adequate analgesia and patient comfort throughout the procedure. During the procedure, a nurse is vital for patient monitoring and medication administration, if necessary, to ensure the patient's safety and comfort. Nurses are among the many members who provide the safety, comfort, and well-being of patients undergoing ESWL procedures. After undergoing ESWL, educating the patient about dietary modifications and informing them about the option of 24-hour urine testing with directed therapy to reduce the risk of recurrent urolithiasis and renal calculi is essential. This proactive approach can significantly contribute to the long-term prevention and management of kidney stones. Close cooperation and communication among the patient's healthcare team members are vital to reinforce this message and ensure optimal treatment results with minimal recurrences. By working together effectively, healthcare professionals can provide comprehensive care and support to patients throughout their treatment journey, improving outcomes and enhancing overall satisfaction.